AR

Ashu Rani

Active Director Director DIN 10378313
DIN 10378313 First appointment Nov 2023 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2023
Shareholding value Locked Premium profile

About Ashu Rani

Ashu Rani has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Hobart Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 10378313
Primary Designation Director
First Appointment 02 Nov 2023
Oldest Company Age 2 yrs

Current companies

Company Designation Appointment Founded Status
Hobart Pharma Private Limited U86909HR2023PTC116190
Director 02 Nov 2023 2023 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hobart Pharma Private Limited
Premium access

Shareholding and investment profile for Ashu Rani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashu Rani

Ashu Rani has 2 years in corporate governance. Holds Director role. Currently with 1 company, including Hobart Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Ashu Rani is associated with 1 company as Director.

Ashu Rani has expertise in General Business.

Ashu Rani has 2 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available